US EditionPHL pharma to gain from US firms’ pivot | Andrea E. San Juan
Summary by BusinessMirror
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
PHL pharma to gain from US firms’ pivot | Andrea E. San Juan
THE Philippine pharmaceutical industry stands to benefit from the relocation of business operations of US multinational pharmaceutical firms as Southeast Asia is positioned to capture this growth opportunity, according to the Philippine Pharmaceutical Manufacturers Association (PPMA). In its economic outlook, BMI, a Fitch Solutions company, noted that Southeast Asia (SEA)…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
